Efficacy, safety, and tolerability of secukinumab in patients with active ankylosing spondylitis: a randomized, double-blind phase 3 study, MEASURE 3
暂无分享,去创建一个
K. Pavelka | A. Kivitz | H. Tahir | R. Blanco | L. Pricop | M. Andersson | E. Dokoupilová | B. Porter | A. Readie | M. Maradiaga